Structure Therapeutics Inc.

Direct answer

Structure Therapeutics Inc. is publicly traded on NASDAQ under the ticker GPCR.

Structure Therapeutics Inc., an international biopharmaceutical company currently in its clinical development phase, is committed to creating and providing groundbreaking oral therapies for various chronic diseases that lack adequate treatment options. The company's primary investigational drug, GSBR-1290, is an orally administered, biased small molecule agonist designed to target the glucagon-like-peptide-1...

Can you invest in Structure Therapeutics Inc.?

Yes. Structure Therapeutics Inc. trades publicly on NASDAQ as GPCR.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Structure Therapeutics Inc.

Detailed equity research is provided by MarketSnap.